Focal Point Pharmaceuticals

Focal Point Pharmaceuticals Overview

Founded 2013
Status Private
Latest Deal Type Early Stage VC
Latest Deal Amount $80K
Latest Deal Amount
Investors 1

Focal Point Pharmaceuticals General Information


Developer of products designed to treat ocular diseases. The company's products are developed with pre-clinical research and lead selection, enabling clients to treat rare diseases, including ocular trauma and other eye diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 40 South Main Street
  • Suite 2300
  • Memphis, TN 38103
  • United States
+1 (484) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Focal Point Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 31-Jan-2017 $80K 00000 Completed Generating Revenue
2. Early Stage VC 14-Aug-2013 00000 00000 Completed Generating Revenue
1. Grant Completed Generating Revenue

Focal Point Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Edward Chaum MD Co-Founder & Chief Scientific Officer
Gary Prosterman Treasurer & Board Member
Raymond Hage Jr. President & Board Member

Focal Point Pharmaceuticals Board Members (3)

Name Representing Role Since
Gary Prosterman Focal Point Pharmaceuticals Treasurer & Board Member 000 0000
Gary Stevenson MB Venture Partners Board Member 000 0000
Raymond Hage Jr. Self President & Board Member 000 0000

Focal Point Pharmaceuticals Investors (1)

To view Focal Point Pharmaceuticals‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MB Venture Partners Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial